1D 1W 1M 3M 6M 1Y 3Y 5Y 10Y
| Index Name | Current Value | Change | % Change |
|---|---|---|---|
| NFTMIDSMLHEALTH | 48454.5 | 263.4 | 0.5% |
| Company Name | Current Value (₹) | Change(₹) | Price(%) |
|---|---|---|---|
| Sai Life Scienc... | 1175.9 | 63.3 | 5.7% |
| Narayana Hruday... | 1940.0 | 85.7 | 4.6% |
| Wockhardt Ltd. | 1637.6 | 62.3 | 4.0% |
| Cohance Lifesci... | 434.9 | 16.4 | 3.9% |
| Glenmark Pharma... | 2337.0 | 77.8 | 3.4% |
| Poly Medicure L... | 1547.2 | -51.6 | -3.2% |
| Ipca Laboratori... | 1571.0 | -30.9 | -1.9% |
| Onesource Speci... | 1806.8 | -27.4 | -1.5% |
| Aster DM Health... | 746.9 | -9.4 | -1.2% |
| Krishna Institu... | 756.8 | -7.3 | -0.9% |
₹ |
1D 1W 1M 3M 6M 1Y 3Y 5Y 10Y
| Sl # | Index Name | Current Value | Change | % Change |
|---|---|---|---|---|
| 1 | Lupin Ltd. | 2287.2 | 7.7 | 0.3% |
| 2 | Abbott India Ltd. | 27705.0 | -118.2 | -0.4% |
| 3 | Glaxosmithkline Pharmaceuticals Ltd. | 2300.1 | -9.7 | -0.4% |
| 4 | Pfizer Ltd. | 4689.2 | 12.3 | 0.3% |
| 5 | JB Chemicals & Pharmaceuticals Ltd. | 2228.4 | 32.1 | 1.5% |
| 6 | Ipca Laboratories Ltd. | 1571.0 | -30.9 | -1.9% |
| 7 | Neuland Laboratories Ltd. | 16758.0 | 124.0 | 0.7% |
| 8 | Aurobindo Pharma Ltd. | 1454.6 | -10.1 | -0.7% |
| 9 | Natco Pharma Ltd. | 1173.0 | 2.7 | 0.2% |
| 10 | Poly Medicure Ltd. | 1547.2 | -51.6 | -3.2% |
| 11 | Glenmark Pharmaceuticals Ltd. | 2337.0 | 77.8 | 3.4% |
| 12 | Wockhardt Ltd. | 1637.6 | 62.3 | 4.0% |
| 13 | Ajanta Pharma Ltd. | 3081.5 | -24.4 | -0.8% |
| 14 | Granules India Ltd. | 758.4 | 6.8 | 0.9% |
| 15 | Biocon Ltd. | 430.1 | -0.2 | 0.0% |
| 16 | Fortis Healthcare Ltd. | 970.4 | 9.9 | 1.0% |
| 17 | Sai Life Sciences Ltd. | 1175.9 | 63.3 | 5.7% |
| 18 | Syngene International Ltd. | 462.4 | 0.6 | 0.1% |
| 19 | Mankind Pharma Ltd. | 2457.5 | -23.0 | -0.9% |
| 20 | Alkem Laboratories Ltd. | 5400.5 | -5.2 | -0.1% |
| 21 | Narayana Hrudayalaya Ltd. | 1940.0 | 85.7 | 4.6% |
| 22 | Dr. Lal Pathlabs Ltd. | 1614.9 | -12.1 | -0.7% |
| 23 | Aster DM Healthcare Ltd. | 746.9 | -9.4 | -1.2% |
| 24 | Krishna Institute of Medical Sciences Ltd | 756.8 | -7.3 | -0.9% |
| 25 | Gland Pharma Ltd. | 2333.8 | 4.6 | 0.2% |
| 26 | Laurus Labs Ltd. | 1356.3 | 13.0 | 1.0% |
| 27 | Global Health Ltd. | 1249.3 | 10.8 | 0.9% |
| 28 | Cohance Lifesciences Ltd. | 434.9 | 16.4 | 3.9% |
| 29 | Piramal Pharma Ltd. | 179.5 | 4.0 | 2.3% |
| 30 | Onesource Specialty Pharma Ltd. | 1806.8 | -27.4 | -1.5% |
| # | Company | CMP | M Cap | 52W High | 52W Low | PE | PB | ROCE Last Yr | ROE Last Yr | PAT TTM | Div Yield |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Lupin Ltd. | 2287.2 | 104574 | 2492 | 1838.6 | 31.6 | 6.1 | 22 | 21.1 | 5355 | 0.6 |
| 2 | Mankind Pharma Ltd. | 2457.5 | 101472 | 2726.8 | 1909.9 | 50.6 | 7.1 | 18.3 | 17 | 1926 | 0 |
| 3 | Aurobindo Pharma Ltd. | 1454.6 | 83694 | 1550 | 1017 | 24 | 2.6 | 14.4 | 11.1 | 3501 | 0 |
| 4 | Fortis Healthcare Ltd. | 970.4 | 73257 | 1105 | 699.1 | 90.5 | 8.2 | 12.1 | 9.8 | 1048 | 0.1 |
| 5 | Laurus Labs Ltd. | 1356.3 | 73221 | 1371.5 | 594 | 206.6 | 16.4 | 10.2 | 8.3 | 890 | 0.2 |
| 6 | Biocon Ltd. | 430 | 69707 | 436.8 | 327.8 | 48.8 | 2.4 | 7.4 | 7 | 369 | 0.1 |
| 7 | Glenmark Pharmaceuticals Ltd. | 2337 | 65950 | 2471 | 1377 | 63 | 7.5 | 16.2 | 12.6 | 1065 | 0.2 |
| 8 | Alkem Laboratories Ltd. | 5400.5 | 64571 | 5933 | 4716.8 | 29.1 | 5.4 | 21.6 | 19.9 | 2424 | 0.9 |
| 9 | Abbott India Ltd. | 27705 | 58871 | 35921.6 | 25164 | 41.6 | 14 | 47.9 | 36 | 1552 | 1.5 |
| 10 | Ipca Laboratories Ltd. | 1571 | 39857 | 1679.4 | 1253 | 50.6 | 5.7 | 15.3 | 11.9 | 948 | 0.3 |
| 11 | Narayana Hrudayalaya Ltd. | 1940 | 39646 | 2371.6 | 1564.2 | 50.2 | 10.9 | 21.6 | 24.3 | 816 | 0.3 |
| 12 | Glaxosmithkline Pharmaceuticals Ltd. | 2300.1 | 38965 | 3516 | 2218 | 42 | 19.8 | 67.6 | 49.4 | 1036 | 1.9 |
| 13 | Aster DM Healthcare Ltd. | 746.9 | 38698 | 776.2 | 519.8 | 114.9 | 12.3 | 11.5 | 9.3 | 464 | 25.4 |
| 14 | Ajanta Pharma Ltd. | 3081.5 | 38499 | 3314.8 | 2335 | 41.8 | 10.2 | 32.9 | 25.1 | 1056 | 1.1 |
| 15 | Gland Pharma Ltd. | 2333.8 | 38451 | 2391.2 | 1515 | 55 | 4.2 | 12 | 7.8 | 1027 | 1.1 |
| 16 | JB Chemicals & Pharmaceuticals Ltd. | 2228.4 | 35779 | 2285 | 1603 | 54.2 | 10.6 | 26.7 | 21.8 | 709 | 1 |
| 17 | Global Health Ltd. | 1249.3 | 33590 | 1455.8 | 955.2 | 69.8 | 9.9 | 20.5 | 15.3 | 554 | 0 |
| 18 | Krishna Institute of Medical Sciences Ltd | 756.8 | 30283 | 798 | 575.6 | 73 | 14.2 | 19 | 20.9 | 239 | 0 |
| 19 | Dr. Lal Pathlabs Ltd. | 1614.9 | 27072 | 1771.3 | 1272 | 55 | 12.8 | 31.5 | 25.2 | 510 | 1 |
| 20 | Wockhardt Ltd. | 1637.6 | 26610 | 1870 | 1086.8 | -466.8 | 6.1 | 4.1 | -1.5 | 199 | 0 |
| 21 | Sai Life Sciences Ltd. | 1175.9 | 24943 | 1185 | 704.4 | 146.6 | 11.5 | 15.5 | 11 | 349 | 0 |
| 22 | Piramal Pharma Ltd. | 179.5 | 23855 | 220.9 | 132.5 | 261.8 | 2.9 | 6.6 | 1.1 | -383 | 0.1 |
| 23 | Neuland Laboratories Ltd. | 16758 | 21500 | 19748.4 | 11022.4 | 82.7 | 14.1 | 23.5 | 18.5 | 364 | 0.1 |
| 24 | Pfizer Ltd. | 4689.2 | 21452 | 5987.6 | 4461.8 | 27.9 | 5.1 | 26.2 | 19.6 | 722 | 4.1 |
| 25 | Natco Pharma Ltd. | 1173 | 21010 | 1226.1 | 789.3 | 11.2 | 2.8 | 32.8 | 28 | 1545 | 0.8 |
| 26 | Onesource Specialty Pharma Ltd. | 1806.8 | 20714 | 2249.6 | 1075 | -1198.7 | 3.5 | 2.6 | -0.6 | -74 | 0 |
| 27 | Granules India Ltd. | 758.4 | 18793 | 772.8 | 433 | 37.5 | 5 | 16.2 | 14.5 | 595 | 0.3 |
| 28 | Syngene International Ltd. | 462.4 | 18666 | 728.4 | 380 | 37.6 | 4 | 15.4 | 11.2 | 317 | 0.2 |
| 29 | Cohance Lifesciences Ltd. | 434.8 | 16636 | 1121.2 | 267.8 | 62.8 | 6.6 | 18.4 | 14.2 | 150 | 0 |
| 30 | Poly Medicure Ltd. | 1547.2 | 15682 | 2431 | 1184 | 46.3 | 5.7 | 20.4 | 16 | 341 | 0.2 |
Looking to buy unlisted shares or need guidance on the investment process? Our expert Private Equity Advisors are here to assist you with accurate information, real-time pricing, and seamless execution.
Want to sell unlisted shares, liquidate your ESOPs, or understand the step-by-step process of liquidation? Connect with our Buying Team for smooth coordination, quick evaluations, and end-to-end support.
Planning to build or grow your portfolio? For Mutual Fund investments, PMS solutions, tailored portfolio creation, and overall wealth management, our dedicated Wealth Team is ready to guide you.
ChatGPT
Claude
Perplexity
